All Stories

  1. Myogenic Differentiation (MyoD) Gene Expression in Cornea and Role in Corneal Myofibroblast Dedifferentiation
  2. ATAC-seq revealing chromatin accessibility and novel motifs linked to corneal fibrosis
  3. Long-Term Tolerability and Safety of AAV5 -Id3 Gene Therapy to Eyes
  4. Identification of dysregulated gene clusters and pathways driving ocular surface squamous neoplasia progression
  5. Topical Rho-Associated Protein Kinase Inhibitor HA1077 Reduces Rabbit Corneal Fibrosis and Neovascularization in Vivo
  6. Enzyme classification integrating LSTM and Prot-BERT sequence encoding
  7. Current progress in research on ocular injury caused by exposure to vesicants
  8. Single-Cell Transcriptomics Shows Cellular Heterogeneity, Intercellular Communication, and Extracellular Matrix Remodeling in Corneal Fibrosis In Vivo
  9. Carbofuran Exposure Alters Autophagy Flux in Human Cornea In Vitro and Ex Vivo
  10. Open-Field Blast Injury Disrupts Corneal Gene Expression Linked to Ion Transport, Sensory Perception, and Neural Signaling
  11. Artificial intelligence derived grading of mustard gas induced corneal injury and opacity
  12. Mustard Gas Induced Corneal Injury Involves Ferroptosis and p38 MAPK Signaling
  13. Identification of Potential Necroptosis Inhibitors using Pharmacophore Model: An In-silico Approach
  14. Transcriptomic landscape of quiescent and proliferating human corneal stromal fibroblasts
  15. RNA-Seq Analysis Unraveling Novel Genes and Pathways Influencing Corneal Wound Healing
  16. Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo
  17. Corneal Scarring
  18. Gene Therapy for Cornea, Conjunctiva, and Lacrimal Gland
  19. Differential gene expression and protein-protein interaction network profiling of sulfur mustard-exposed rabbit corneas employing RNA-seq data and bioinformatics tools
  20. Deep learning-based prediction model for diagnosing gastrointestinal diseases using endoscopy images
  21. Pathophysiology, Current Therapeutic Options, Vaccine Candidates, and Drug Targets for Human Brucellosis
  22. Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics
  23. Corneal gene therapy: Structural and mechanistic understanding
  24. Artificial intelligence in intestinal polyp and colorectal cancer prediction
  25. Investigating molecular features that influence blood − brain barrier permeability of compounds
  26. Neuronal Vulnerability to Degeneration in Parkinson’s Disease and Therapeutic Approaches
  27. Unlocking the microbial studies through computational approaches: how far have we reached?
  28. Smelling the Disease: Diagnostic Potential of Breath Analysis
  29. Ligand-based Pharmacophore Modeling, Molecular Docking and Simulation Studies for the Exploration of Natural Potent Antiangiogenic Inhibitors Targeting Heat Shock Protein 90
  30. Artificial Intelligence in De novo Drug Design: Are We Still There?
  31. Developing human olfactory network and exploring olfactory receptor-odorant interaction
  32. Recent Applications of Artificial Intelligence in Early Cancer Detection
  33. Decoding seven basic odors by investigating pharmacophores and molecular features of odorants
  34. DeePred-BBB: A Blood Brain Barrier Permeability Prediction Model With Improved Accuracy
  35. Epigenetic Modifications by Estrogen and Androgen in Alzheimer’s Disease
  36. Screening of potential antigens from whole proteome and development of multi-epitope vaccine against Rhizopus delemar using immunoinformatics approaches
  37. DeepOlf: Deep Neural Network Based Architecture for Predicting Odorants and Their Interacting Olfactory Receptors
  38. Recent Applications of Artificial Intelligence in the Detection of Gastrointestinal, Hepatic and Pancreatic Diseases
  39. Crosstalk between epigenetics and mTOR as a gateway to new insights in pathophysiology and treatment of Alzheimer's disease
  40. OlfactionBase: a repository to explore odors, odorants, olfactory receptors and odorant–receptor interactions
  41. Deep Learning in Disease Diagnosis: Models and Datasets
  42. OBPred: feature-fusion-based deep neural network classifier for odorant-binding protein prediction
  43. Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine
  44. Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19
  45. A deep neural network–based approach for prediction of mutagenicity of compounds
  46. Development of Machine Learning based blood-brain barrier permeability prediction models using physicochemical properties, MACCS and substructure fingerprints
  47. Hydroxychloroquine in COVID-19: therapeutic promises, current status, and environmental implications
  48. SMILES to Smell: Decoding the Structure–Odor Relationship of Chemical Compounds Using the Deep Neural Network Approach
  49. Dissecting Sex‐Related Cognition between Alzheimer’s Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies
  50. Available Compounds With Therapeutic Potential Against COVID-19: Antimicrobial Therapies, Supportive Care, and Probable Vaccines
  51. Therapeutic Promises of Chlorogenic Acid with Special Emphasis on its Anti-Obesity Property
  52. Blood Brain Barrier Permeability Prediction Using Machine Learning Techniques: An Update
  53. Sense of Smell: Structural, Functional, Mechanistic Advancements and Challenges in Human Olfactory Research
  54. Computational Outlook of Marine Compounds as Anti-Cancer Representatives Targeting BCL-2 and Survivin
  55. Prediction of Elimination of Compounds Using Artificial Intelligence Techniques
  56. Prediction of Drug-Plasma Protein Binding Using Artificial Intelligence Based Algorithms
  57. Promises of Machine Learning Approaches in Prediction of Absorption of Compounds
  58. Prediction of Human Intestinal Absorption of Compounds Using Artificial Intelligence Techniques
  59. Prediction of Metabolism of Drugs using Artificial Intelligence: How far have we reached?
  60. Can we predict blood brain barrier permeability of ligands using computational approaches?
  61. Prospects of Nano–Material in Breast Cancer Management
  62. Advanced stage of breast cancer hoist alkaline phosphatase activity: risk factor for females in India
  63. Brain Region Specific Monoamine and Oxidative Changes During Restraint Stress
  64. Novel Ocimumoside A and B as anti-stress agents: Modulation of brain monoamines and antioxidant systems in chronic unpredictable stress model in rats
  65. Application of microarray in breast cancer: An overview
  66. A comparative study of support vector machine, artificial neural network and Bayesian classifier for mutagenicity prediction
  67. Purification, Characterization, Sequencing and Biological Chemistry of Galectin-1 Purified from Capra hircus (goat) Heart
  68. A prediction model for oral bioavailability of drugs using physicochemical properties by support vector machine
  69. Stem cells: An overview with respect to cardiovascular and renal disease